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Both stroke and diabetes mellitus (dm)are increasingly common conditions that contr- ibute to worldwide morbidity and mortality, thus 
necessitating urgent action. Globally, there were 33 million 
estimated cases of stroke in 2013, with a loss of 39.4 and 
62.8 million disability-adjusted life years (DALYs) due 
to ischaemic and haemorrhagic stroke, respectively.1,2 
Furthermore, stroke was the second most common cause 
of death (11.8%) and the third most common cause of 
disability (4.5%).2 A systematic review of 64 studies from 
the Middle East indicated incidence and prevalence rates 
of 22.7–250 and 508–777 per 100,000 people per year, 
respectively.3 Over the next 20 years, stroke-related 
mortality is predicted to triple in Africa, the Middle East 
and in Latin American countries.4 In 2014, an estimated 
422 million adults worldwide had DM, with the prev- 
alence almost doubling from 4.7% in 1980 to 8.5% in 
2014, the greatest burden of which was in low- and 
middle-income countries.5,6 In the Eastern Mediterr-
anean region, the prevalence of DM is particularly high 
(3.5–30%), with Gulf Cooperation Council countries 
observed to have some of the highest DM prevalence 
rates in the region.7
Diabetes is associated with several neurological 
disorders, with stroke being the most well-recognised 
and, likely, the most common. Diabetes is known to 
influence almost all varieties of stroke, including large 
artery stroke due to atherosclerosis, lacunar stroke and, 
possibly, intracerebral haemorrhage due to microvasc-
ular injury and embolic stroke due to diabetes; the latter 
of which is a significant risk factor for atrial fibrillation 
and hence part of risk factor assessment.8 Diabetic indiv- 
iduals have a 2.5–3.6-times higher risk of stroke compared 
to non-diabetics, with diabetic women at an increased risk 
compared to men.5,9–11 Rammal et al. estimated the prev- 
alence of diabetes in ischaemic stroke to be 37.5% in 
the Arab world, based on an analysis of 29 studies of 
10,242 patients.12 In an unpublished case-control study 
conducted in Oman, the prevalence of DM was 62.3% 
versus 44.7% among ischaemic stroke cases compared 
to controls (P <0.001).13 In another study from Oman 
based on stroke registry data, 52% of 600 patients with 
ischaemic stroke had diabetes.14
A growing body of literature in recent decades has 
recognised the link between DM and cerebral atrophy, 
as well as cognitive dysfunction.8,15–18 The strong inter- 
relationship between DM and stroke may be due not 
only to micro- and macrovascular injuries associated 
with DM, but also to other shared risk factors such 
as genetic, demographic and lifestyle factors that are 
likely influenced by age and gender.8 In terms of the 
mechanism of vascular injury in diabetes, evidence indic- 
ates that hyperglycaemia (and possibly insulin resistance) 
leads to oxidative stress and the overproduction of reactive 
oxygen species, triggering multiple biochemical path- 
ways and, ultimately, endothelial dysfunction and vasc- 
ular injury.8,15 Early endothelial changes may lead to accel- 
erated macrovascular atherosclerosis as well as changes 
in microvascular blood flow control and permeability.16 
The phenomenon of ‘metabolic memory’ complicates 
the course of DM, with a prolonged progression of micro- 
and macrovascular complications observed, even after 
prompt and intensive glycaemic control.17 Currently, 
mechanisms of nonvascular brain injury are still being 
explored. Several of the above mechanisms as well as 
endothelial dysfunction, alterations in blood brain barrier 
function and inflammation may contribute to nonvascular 
neurological injury.18 
In view of the strong relationship between diabetes 
and stroke, it is natural to explore various methods of 
cerebrovascular evaluation to better understand the 
pathophysiology of these conditions or to predict epis- 
odes of cerebrovascular injury. Carotid Doppler ultra-
sonography is a relatively simple and noninvasive method 
of visualising the superficial blood vessels and can be 
used to clinically evaluate the cervical carotid and parts 
of the vertebral arteries in the context of stroke. Using 
Doppler ultrasonography, the carotid intima media thick- 
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ness (CIMT) can be measured and used as surrogate 
evidence of vascular injury as thickening of the tunica 
intima is known to be a precursor of atherosclerosis.19,20 
The cervical carotid arteries are a fairly easy and conv-
enient location to study this, particularly as they are 
also the location of the atherosclerotic plaques that lead 
to stroke. Vascular ultrasonography is another simple 
method of quantifying the extent of arterial narrowing, 
as measured by the diameter or cross-sectional area 
of the lumen or by recognising turbulent changes in 
blood flow.19,20 
In this issue of SQUMJ, Nazish et al. have published 
a retrospective study in which they report a relationship 
between glycated haemoglobin (HbA1c) and CIMT and 
carotid plaques among adult ischaemic stroke patients 
who underwent carotid Doppler ultrasonography in 
addition to brain imaging.21 The authors found a signif- 
icant association between mean HbA1c levels and incr- 
eased CIMT, but not with the presence of carotid plaques. 
A regression analysis indicated that dyslipidaemia and 
age were independently correlated with high CIMT, 
but not with HbA1c levels.21 The results of this study 
are similar to those of other studies exploring the 
role of carotid ultrasound CIMT and plaque findings 
as surrogate risk factors for stroke in general, as well 
as among patients with diabetes.20,22,23 However, the 
strength of the relationship between CIMT and stroke 
among diabetic patients has not yet been determined. 
Increased CIMT has been associated with other factors 
influencing stroke, such as hypertension, hyperlip-
idaemia, smoking, obesity, advanced age and genetic 
factors.24 In addition, while some studies have demonstr- 
ated CIMT to be a risk factor for diabetes, others have 
demonstrated only an association on univariate analysis 
and not as an independent risk factor.23 Nevertheless, 
community-based studies of vascular changes are of 
value because they enhance our understanding of the 
underlying pathophysiological mechanisms of these 
conditions; in addition, such research may inform future 
targets of therapy or be used as markers of treatment 
efficacy.19,20,25 
Apart from vascular ultrasonography, other methods 
may be of use when exploring the complex interactions 
between diabetes and brain dysfunction. As mentioned 
earlier, diabetes is a risk factor for other mechanisms 
of brain injury leading to cerebral small vessel disease 
(CSVD), non-stroke brain atrophy and cognitive dysf- 
unction.18 With magnetic resonance imaging (MRI), 
CSVD is now recognised to comprise a spectrum of 
brain changes including periventricular hyperintens-
ities, lacunar stroke, intracerebral micro- and macro-
haemorrhage, enlarged perivascular spaces and cortical 
siderosis.26,27 Several studies have demonstrated an assoc- 
iation between diabetic retinopathy and lacunar stroke 
as well as cognitive dysfunction, although the relation 
between CSVD and diabetic microangiopathy is not yet 
clear.26–28 Apart from conventional changes observed 
in diabetic retinopathy, such as retinal haemorrhage 
and changes in vascular diameter, novel methods such 
as optical coherence tomography, retinal vasculature 
fractal dimension and laser flowmetry are being explored 
as methods of detecting brain injury.18,29 Using video- 
capillaroscopy, microvasculature changes in the nail bed 
can be quantified and have been utilised to demonstrate 
a relationship with diabetic microangiopathy; this 
method could potentially be explored as a surrogate 
marker for brain injury.30 Skin autofluorescence, which 
reflects the accumulation of advanced glycation end-
products in diabetes, has been associated with brain 
cortical atrophy.31
Overall, MRI is a sensitive method of studying 
structural changes in the brain. A review of studies 
addressing MRI findings among diabetic subjects indic-
ated that diffuse brain atrophy as well as increased CSVD 
changes were associated with diabetes; such changes are 
only explained in part by age and the presence of other 
adverse vascular risk factors.32 MRI is also useful in the 
detection of microstructural brain lesions among diabetic 
subjects.32,33 Attempts to link MRI findings of struct-
ural brain abnormalities to histology results may, for 
example, advance our understanding of the role of 
diabetic microvascular disease in the context of brain 
injury. While such methods of studying the relation 
between diabetes and brain injury may help predict 
neurological dysfunction, a more attractive application 
would be to monitor novel treatments.
In conclusion, large artery stroke due to accelerated 
atherosclerosis is only one mechanism of neurological 
injury associated with diabetes, with several other mech- 
anisms well recognised in relation to diabetes. Cerebro- 
vascular atherosclerosis can be easily explored using 
vascular Doppler ultrasonography and angiography. 
However, CSVD as well as nonvascular diabetic 
encephalopathy are conditions that may also be 
explored clinically based on other methods such as 
retinal or skin vascular changes or utilising advanced 
brain MRI modalities. More studies are necessary to 
explore the utility of the latter approach in predicting 
neurobehavioural changes in patients with diabetes, 
enhancing our understanding of its pathophysiology 
and developing better methods of managing 
these conditions.
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